MELANOMA (SKIN)
Clinical trials for MELANOMA (SKIN) explained in plain language.
Never miss a new study
Get alerted when new MELANOMA (SKIN) trials appear
Sign up with your email to follow new studies for MELANOMA (SKIN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests novel cancer vaccine injection
Disease control OngoingThis early-stage study is testing the safety of a new experimental cancer vaccine called PeptiCRAd-1 when given alongside the immunotherapy drug pembrolizumab. The trial involves 15 adults with various advanced solid tumors that have specific markers. Researchers will inject the …
Matched conditions: MELANOMA (SKIN)
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New vaccine booster shots tested to supercharge melanoma treatment
Disease control OngoingThis study is testing whether adding one of two experimental cancer vaccines (SCIB1 or iSCIB1+) to standard immunotherapy drugs can improve outcomes for people with advanced, inoperable melanoma. The goal is to see if the vaccines help patients respond better to treatment and kee…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE2 • Sponsor: Scancell Ltd • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New approach tries to outsmart aggressive skin cancer
Disease control OngoingThis small, early study is testing a flexible treatment schedule for people with advanced melanoma that has a specific genetic change (BRAF mutation). It combines two drugs that target the cancer's growth signals with an immunotherapy drug that helps the immune system fight the c…
Matched conditions: MELANOMA (SKIN)
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Four-Week drug blitz tested to stop deadly skin Cancer's comeback
Disease control OngoingThis large study tested whether a short, intense 4-week course of a drug called interferon alfa-2b could help prevent melanoma skin cancer from coming back after it had been surgically removed. It compared the drug treatment to simply watching patients closely (observation) in ov…
Matched conditions: MELANOMA (SKIN)
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC